Animal models of neuropsychiatric disorders

Eric J Nestler; Steven E Hyman

doi:10.1038/nn.2647

journal article Sep 27, 2010

Animal models of neuropsychiatric disorders

Eric J Nestler Steven E Hyman

Nature Neuroscience Vol. 13 No. 10 pp. 1161-1169 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nn.2647

Topics

No keywords indexed for this article. Browse by subject →

References

71

[1]

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Ronald C. Kessler, Patricia Berglund, OLGA DEMLER et al.

Archives of General Psychiatry 2005 10.1001/archpsyc.62.6.593

[2]

Age of onset of mental disorders: a review of recent literature

Ronald C Kessler, G Paul Amminger, Sergio Aguilar-Gaxiola et al.

Current Opinion in Psychiatry 2007 10.1097/yco.0b013e32816ebc8c

[3]

World Health Organization. World Health Report 2001 (World Health Organization, Geneva, 2001).

[4]

Nestler, E.J., Hyman, S.E. & Malenka, R.C. Molecular Neuropharmacology: a Foundation for Clinical Neuroscience, 2nd edn (McGraw-Hill, New York, 2009).

[5]

Markou, A., Chimmulera, C., Geyer, M.A., Tricklebank, M. & Steckler, T. Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 34, 74–89 (2009). 10.1038/npp.2008.173

[6]

Diagnostic and Statistical Manual of Mental Disorders. 4th edn, text revision (American Psychiatric Association Press, Washington, DC, 2000).

[7]

The Diagnosis of Mental Disorders: The Problem of Reification

Steven E. Hyman

Annual Review of Clinical Psychology 2010 10.1146/annurev.clinpsy.3.022806.091532

[8]

Götz, J. & Ittner, L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9, 532–544 (2008). 10.1038/nrn2420

[9]

Morrissette, D.A., Parachikova, A., Green, K.N., & LaFerla, F.M. . Relevance of transgenic mouse models to human Alzheimer disease. J. Biol. Chem. 284, 6033–6037 (2009). 10.1074/jbc.r800030200

[10]

Krishnan, V. & Nestler, E.J. Molecular neurobiology of depression. Nature 455, 894–902 (2008). 10.1038/nature07455

[11]

Welch, J.M. et al. Cortico-striatal synaptic defects and OCD-like behaviors in Sapap3-mutant mice. Nature 448, 894–900 (2007). 10.1038/nature06104

[12]

Chen, S.-K. et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141, 775–785 (2010). 10.1016/j.cell.2010.03.055

[13]

Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243–254 (2002). 10.1016/s0896-6273(02)00768-7

[14]

A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice

Katsuhiko Tabuchi, Jacqueline Blundell, Mark R. Etherton et al.

Science 2007 10.1126/science.1146221

[15]

Jamain, S. et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. USA 105, 1710–1715 (2008). 10.1073/pnas.0711555105

[16]

Morrow, E.M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218–223 (2008). 10.1126/science.1157657

[17]

Moy, S.S. & Nadler, J.J. Advances in behavioral genetics: mouse models of autism. Mol. Psychiatry 13, 4–26 (2008). 10.1038/sj.mp.4002082

[18]

Buxbaum, J.D. Multiple rare variants in the etiology of autism spectrum disorders. Dialogues Clin. Neurosci. 11, 35–43 (2009). 10.31887/dcns.2009.11.1/jdbuxbaum

[19]

Etherton, M.R., Blaiss, C.A., Powell, C.M. & Sudhof, T.C. Mouse neurexin-1 alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. USA 106, 17998–18003 (2009). 10.1073/pnas.0910297106

[20]

Silverman, J.L., Yang, M., Lord, C. & Crawley, J.N. Behavioral phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490–502 (2010). 10.1038/nrn2851

[21]

Molecular and Cellular Approaches for Diversifying and Extending Optogenetics

Viviana Gradinaru, Feng Zhang, Charu Ramakrishnan et al.

Cell 2010 10.1016/j.cell.2010.02.037

[22]

Chadman, K.K., Yang, M. & Crawley, J.N. Criteria for validating mouse models of psychiatric diseases. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 1–11 (2009). 10.1002/ajmg.b.30777

[23]

International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009). 10.1038/nature08185

[24]

Aguzzi, A., Sigurdson, C. & Heikenwaelder, M. Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol. 3, 11–40 (2008). 10.1146/annurev.pathmechdis.3.121806.154326

[25]

Green, J.G. et al. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I. Arch. Gen. Psychiatry 67, 113–123 (2010). 10.1001/archgenpsychiatry.2009.186

[26]

A Systematic Review of the Prevalence of Schizophrenia

Sukanta Saha, David Chant, Joy Welham et al.

PLoS Medicine 2005 10.1371/journal.pmed.0020141

[27]

Tamminga, C.A. The neurobiology of cognition in schizophrenia. J. Clin. Psychiatry 67 Suppl 9, 9–13 (2006).

[28]

Keefe, R.S.E. et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 64, 633–647 (2007). 10.1001/archpsyc.64.6.633

[29]

Swerdlow, N.R., Weber, M., Qu, Y., Light, G.A. & Braff, D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl.) 199, 331–388 (2008). 10.1007/s00213-008-1072-4

[30]

Cannon, T.D. et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl. Acad. Sci. USA 99, 3228–3233 (2002). 10.1073/pnas.052023499

[31]

Lewis, D.A. & Sweet, R.A. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest. 119, 706–716 (2009). 10.1172/jci37335

[32]

Lewis, D.A. & Moghaddam, B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric adic and glutamate alterations. Arch. Neurol. 63, 1372–1376 (2006). 10.1001/archneur.63.10.1372

[33]

Kegeles, L.S. et al. Increased synaptic dopamine function in associate regions of the striatum in schizophrenia. Arch. Gen. Psychiatry 67, 231–239 (2010). 10.1001/archgenpsychiatry.2010.10

[34]

Arguello, P.A., Markx, S., Gogos, J.A. & Kraiorgou, M. Development of animal models for schizophrenia. Dis. Model Mech 3, 22–26 (2010). 10.1242/dmm.003996

[35]

Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008). 10.1126/science.1155174

[36]

Green, T. et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J. Am. Acad. Child Adolesc. Psychiatry 48, 1060–1068 (2009). 10.1097/chi.0b013e3181b76683

[37]

Karayiorgou, M. Simon, T.J., & Gogos, J.A. 22q11.2 microdeletions:linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 11, 402–416 (2010). 10.1038/nrn2841

[38]

Pletnikov, M.V. et al. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 13, 173–186 (2008). 10.1038/sj.mp.4002079

[39]

Brandon, N.J. et al. Understanding the role of DISC1 in psychiatric disease and during normal development. J. Neurosci. 29, 12768–12775 (2009). 10.1523/jneurosci.3355-09.2009

[40]

Diaz-Asper, C.M. et al. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol. Psychiatry 63, 72–79 (2008). 10.1016/j.biopsych.2007.03.031

[41]

Allen, N.C. et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the Sz database. Nat. Genet. 40, 827–834 (2008). 10.1038/ng.171

[42]

Barnett, J.H., Scoriels, L. & Munafo, M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol. Psychiatry 64, 137–144 (2008). 10.1016/j.biopsych.2008.01.005

[43]

Patterson, P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 204, 313–321 (2009). 10.1016/j.bbr.2008.12.016

[44]

Belforte, J.E. et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13, 76–83 (2010). 10.1038/nn.2447

[45]

Kellendonk, C. et al. Tranient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49, 603–615 (2006). 10.1016/j.neuron.2006.01.023

[46]

Simpson, E.H., Kellendonk, C. & Kandel, E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schziphrenia. Neuron 65, 585–596 (2010). 10.1016/j.neuron.2010.02.014

[47]

Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90–110 (2005). 10.1159/000087097

[48]

Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions

Vaishnav Krishnan, Ming-Hu Han, Danielle L. Graham et al.

Cell 2007 10.1016/j.cell.2007.09.018

[49]

Chuang, J.C. et al. A b3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress. Biol. Psychiatry 67, 1075–1082 (2010). 10.1016/j.biopsych.2009.12.003

[50]

Maternal Care, Gene Expression, and the Transmission of Individual Differences in Stress Reactivity Across Generations

Michael J Meaney

Annual Review of Neuroscience 2001 10.1146/annurev.neuro.24.1.1161

Showing 50 of 71 references

Cited By

1,762

Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review

Margery J.Q. Chen, David Chen-Li · 2025

Psychiatry Research

AKT and MAPK signaling pathways in hippocampus reveals the pathogenesis of depression in four stress-induced models

Xuemei Li, Teng Teng · 2023

Translational Psychiatry

Sex Differences in the Brain Transcriptome Related to Alcohol Effects and Alcohol Use Disorder

Robert Hitzemann, Susan E. Bergeson · 2022

Biological Psychiatry

An overview of the currency and usefulness of behavioral tests used from past to present to assess anxiety, social behavior and depression in rats and mice

Burcu Acikgoz, Bahar Dalkiran · 2022

Behavioural Processes

The prefrontal cortex, pathological anxiety, and anxiety disorders

Margaux M. Kenwood, Ned H. Kalin · 2021

Neuropsychopharmacology

Shared Transcriptional Signatures in Major Depressive Disorder and Mouse Chronic Stress Models

Joseph R. Scarpa, Mena Fatma · 2020

Biological Psychiatry

Circadian rhythm disruption and mental health

William H. Walker, James C. Walton · 2020

Translational Psychiatry

Assessing behavior and cognition in rodents, nonhuman primates, and humans: where are the limits of translation?

Marius Stephan, Paul Volkmann · 2019

Dialogues in Clinical Neuroscience

In vivo Diffusion Tensor Magnetic Resonance Tractography of the Sheep Brain: An Atlas of the Ovine White Matter Fiber Bundles

Valentina Pieri, Marco Trovatelli · 2019

Frontiers in Veterinary Science

Hippocampal GABAergic Inhibitory Interneurons

Kenneth A. Pelkey, Ramesh Chittajallu · 2017

Physiological Reviews

An adverse early life environment can enhance stress resilience in adulthood

Sara Santarelli, Christoph Zimmermann · 2017

Psychoneuroendocrinology

Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling

Yeunkum Lee, Sun Gyun Kim · 2017

Frontiers in Molecular Neuroscience

A Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate Cortex

Ricardo Orozco-Solís, Emilie Montellier · 2017

Biological Psychiatry

New Hippocampal Neurons Mature Rapidly in Response to Ketamine But Are Not Required for Its Acute Antidepressant Effects on Neophagia in Rats

Amelie Soumier, Rayna M. Carter · 2016

eneuro

Improvement of attention with amphetamine in low- and high-performing rats

Karly M Turner, Thomas H J Burne · 2016

Psychopharmacology

Immobility in the forced swim test is adaptive and does not reflect depression

Marc L. Molendijk, E. Ronald de Kloet · 2015

Psychoneuroendocrinology

Illuminating circuitry relevant to psychiatric disorders with optogenetics

Elizabeth E Steinberg, Daniel J Christoffel · 2015

Current Opinion in Neurobiology

AMIGO-Kv2.1 Potassium Channel Complex is Associated With Schizophrenia-Related Phenotypes

Marjaana A. Peltola, Juha Kuja-Panula · 2015

Schizophrenia Bulletin

The role of maternal care in shaping CNS function

Benjamin Nephew, Chris Murgatroyd · 2013

Neuropeptides

GABAergic interneuron origin of schizophrenia pathophysiology

Kazu Nakazawa, Veronika Zsiros · 2012

Neuropharmacology

Metrics

1,762

Citations

71

References

Details

Published: Sep 27, 2010
Vol/Issue: 13(10)
Pages: 1161-1169
License: View

Authors

Cite This Article

Eric J Nestler, Steven E Hyman (2010). Animal models of neuropsychiatric disorders. Nature Neuroscience, 13(10), 1161-1169. https://doi.org/10.1038/nn.2647

Animal models of neuropsychiatric disorders

You May Also Like